Thanks to the new developments at RMIT, we now look to have an answer to the failing anti-bacterial qualities of Penicillin.
With Big Pharma ignoring the perils associated with resistant bugs like Golden Staph, e-coli and Candida, RMIT PhD candidate Priscila Cardoso has successfully developed a new antimicrobial peptide called Priscilicidin.
Within 10 years we are likely to see topical creams and tablets that will be able to resist the super bugs on the market.
Producers: